![](/img/cover-not-exists.png)
The impact of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
AlHilli, M., Bakkum-Gamez, J.N., Mariani, A., Shridhar, V., Cliby, B.A., McGree, M., Weaver, A.L., Dowdy, S.C., Podratz, K.C.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.391
Date:
April, 2015
File:
PDF, 112 KB
english, 2015